Idenix Pharmaceuticals (IDIX)
Idenix Pharmaceuticals Revenues: 35.64M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
IDIX Revenues Rankings
| Overall | 30th percentile | 3085 of 4425 |
| Sector | 54th percentile | 215 of 470 in Healthcare |
| Industry | 75th percentile | 32 of 132 in Biotechnology |
IDIX Revenues Range, Past 5 Years
| Minimum | -0.732M | Dec 2011 |
| Maximum | 35.64M | Mar 2012 |
| Average | 5.935M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these IDIX related companies
IDIX News
@johnkelly $IDIX Montruous activity today as well, something is going on.
about 22 hours ago by littleguy
about 22 hours ago by littleguy
thu $IDIX hype seemz 2 have reeturned. huge call volume on OTM callz yesterday. pickin up sum ITMs 2day
about a day ago by johnkelly
about a day ago by johnkelly
$IDIX HighGrowthFinancial told me a few weeks ago after it hit 9.35 and went back to 785ish that the chart looked good and dont worry.
about a day ago by GArgondizza
about a day ago by GArgondizza
$IDIX Option Bulls Take Another Shot on Idenix. Pete Najarian. http://stks.co/3zAL
about a day ago by littleguy
about a day ago by littleguy
$IDIX Any buyout talk? I'd like to hit the INHX, Pharmasset, Idenix trifecta. Nobody likes Hep C more than me
about a day ago by Grossgrossgross
about a day ago by Grossgrossgross
$IDIX where is EXP. yeah. Calls expired worthless a while ago but long 3000 shares in the 11's
about 2 days ago by PeruvianKnightmare
about 2 days ago by PeruvianKnightmare
$IDIX still marching, spending more confirmation time on da BULLS side
about 2 days ago by HighGrowthFinancial
about 2 days ago by HighGrowthFinancial
Brean Murray Sees Recent Upside in Idenix (IDIX) Related to Possible Gilead (GILD) Settlement in June
May 24, 5:14PM Street Insider
May 24, 5:14PM Street Insider
@GArgondizza @johnkelly Why the love affair with $IDIX today? Don't see any news pending.
about 2 days ago by PattyA_F
about 2 days ago by PattyA_F
$IDIX Getting a bit extended! Be careful, stay disciplined! http://chart.ly/veumy3r
about 2 days ago by TeejTime2
about 2 days ago by TeejTime2
Idenix Pharma having a nice day today and trending on StockTwits into the close http://stks.co/3yjY $IDIX
about 2 days ago by StockTwits
about 2 days ago by StockTwits
from a month ago.. taking its sweet time RT @BlackBetty $IDIX temp target 10.7
about 2 days ago by BlackBetty
about 2 days ago by BlackBetty
Idenix Pharmaceuticals' CEO Presents at Deutsche Bank 37th Annual Healthcare Conference (Transcript)
May 07, 7:46PM Seeking Alpha
May 07, 7:46PM Seeking Alpha
Idenix Pharmaceuticals Reports First Quarter 2012 Financial Results and HCV Development Program Progress
May 02, 4:05PM GlobeNewswire
May 02, 4:05PM GlobeNewswire
Idenix Pharma (IDIX) Rips, Reports Encouraging Data from IDX719 Phase I
Apr 19, 9:21AM Street Insider
Apr 19, 9:21AM Street Insider
Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs
Apr 19, 7:53AM Benzinga
Apr 19, 7:53AM Benzinga
Credit Suisse Assumes Coverage on Idenix Pharmaceuticals Inc. (IDIX) at Neutral
Apr 17, 7:47AM Street Insider
Apr 17, 7:47AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IDIX | 9.68 | -0.40 | -3.97% | 1.041B |
| ICGE | 8.79 | -0.11 | -1.24% | 329.98M |
| ICF | 75.36 | -0.33 | -0.44% | |
| ICCC | 5.950 | -0.00 | -0.00% | 17.97M |
| IBM | 194.30 | -1.79 | -0.91% | 225.13B |
| IBKR | 14.38 | +0.23 | +1.63% | 655.44M |
| IBKC | 48.84 | -0.36 | -0.73% | 1.436B |
| IBI | 17.94 | -0.18 | -0.99% | 566.90M |
| IBCP | 3.35 | -0.01 | -0.30% | 28.61M |
| IBA | 20.55 | +0.53 | +2.65% | 1.028B |